Schedule 13D ownership disclosure

RTI BIOLOGICS INC COM

Security class unavailable · CUSIP: 86882C105

Event date: 2022-01-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,076,229
Percent of class
6.4700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-22-003197
Form type
SC 13D
Filer
SURGALIGN HOLDINGS, INC.
CIK
CIK 1760173
Filed
Feb 04, 2022
Reporting period
Jan 27, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub